Advertisement
Advertisement
U.S. Markets open in 3 hrs 34 mins
Advertisement
Advertisement
Advertisement
Advertisement

Calyxt, Inc. (CLXT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.1660-0.0267 (-13.86%)
At close: 04:00PM EDT
0.1740 +0.01 (+4.82%)
After hours: 07:04PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1927
Open0.1900
Bid0.0000 x 3200
Ask0.0000 x 4000
Day's Range0.1634 - 0.1928
52 Week Range0.1630 - 4.0800
Volume482,538
Avg. Volume523,441
Market Cap6.392M
Beta (5Y Monthly)2.16
PE Ratio (TTM)N/A
EPS (TTM)-1.3230
Earnings DateMar 02, 2022 - Mar 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.24
  • PR Newswire

    Calyxt, Inc. Exploring Strategic Alternatives

    Calyxt, Inc. (NASDAQ: CLXT) ("Calyxt"), a plant-based synthetic biology company, today announced that its Board of Directors is evaluating potential strategic alternatives to maximize shareholder value. As part of the process, the Board is considering a full range of strategic alternatives, which may include financing alternatives, merger, reverse merger, other business combinations, sale of assets, licensing, or other transactions. Calyxt has retained Canaccord Genuity as its financial advisor

  • PR Newswire

    Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference

    Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, President and Chief Executive Officer, and Bill Koschak, Chief Financial Officer, will present at the H.C Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022.

  • Zacks

    Bears are Losing Control Over Calyxt (CLXT), Here's Why It's a 'Buy' Now

    Calyxt (CLXT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Advertisement
Advertisement